Recio Cruz, Carlota Pilar

Researcher

Publicaciones

All

Articles

Conference Papers

Annotation

Lecture

Others

Type

By researcher

Title Issue Date
Endogenous LXR signaling controls pulmonary surfactant homeostasis and prevents lung inflammation Hernández Hernández, Irene; De La Rosa Medina, Juan Vladimir; Martín Rodríguez, Patricia; Diaz Sarmiento,Maria Mercedes; Recio Cruz, Carlota Pilar Issued date: 2024 DOI: 10.1007/s00018-024-05310-3 Source: Cellular and Molecular Life Sciences [ISSN 1420-682X], v. 81 (287), (Julio 2024) SJR: 2,274 - Q1 JCR: 6,2 - Q1 SCIE MIAR ICDS: 10,9 Artículo
Transcriptomic and lipid profiling analysis reveals a functional interplay between testosterone and growth hormone in hypothyroid liver Fernández Pérez, Leandro Fco; Guerra Hernández, Carlos Borja; Recio Cruz, Carlota Pilar; Cabrera Galván,Juan José; García, Irma, et al Issued date: 2023 DOI: 10.3389/fendo.2023.1266150 Source: Frontiers in Endocrinology [1664-2392 ], v. 14:1266150 SJR: 1,24 - Q1 JCR: 3,9 - Q2 SCIE MIAR ICDS: 10,5 Artículo
Lipophilic statins potentiate in vitro antitumoral activity of dihydrofolate reductase inhibitors: repositioning cholesterol-lowering drugs in Oncohematology Guerra Hernández, Carlos Borja; De Mirecki Garrido, Mercedes; Aranda Tavío, Haidée Magdalena; Recio Cruz, Carlota Pilar; Fernández Santana, Yeray Issued date: 2023 Source: 19th World Congress of Basic & Clinical Pharmacology / British Pharmacological Society, pág. 576, #P0964 (Glasgow, 2-7 de julio de 2023) Actas de congresos
Discovery, molecular modeling and biological evaluation of 1,3,5-triaril-pyrazole derivatives as novel Estrogen Receptor Modulators Lopez Rojas, Priscila; Amesty, ángel; Fernández Santana, Yeray; Guerra Rodríguez, Miguel Alfonso; Santana Viera, Sergio Issued date: 2023 Source: 19th World Congress of Basic & Clinical Pharmacology / British Pharmacological Society, p. 580-581, #P0967 (Glasgow, 2-7 de julio de 2023) Actas de congresos
Discovery, molecular modeling and biological evaluation of 1,3,5-triaril-pyrazole derivates as novel Estrogen Receptor Modulators López Rojas, Priscila; Amesty, Ángel; Fernández Sánchez, Yeray; Guerra Rodríguez, Miguel; Santana Viera, Sergio Issued date: 2023 Source: Brithis Journal of Pharmacology [ISSN 0007-1188, eISSN 1476-5381 ], v. 180 (1), p. 580-581, (Julio 2023) Póster de congresos
La interacción de las galectinas-1, -3 y -9 en la respuesta inmunoinflamatoria subyacente a las enfermedades cardiovasculares y metabólicas Mansour, Adel Abo; Krautter, Franziska; Zhi, Zhaogong; Iqbal, Asif Jilani; Recio Cruz, Carlota Pilar Issued date: 2022 DOI: 10.1186/s12933-022-01690-7 Source: Cardiovascular Diabetology [EISSN 1475-2840], v. 21 (1), (Diciembre 2022) SJR: 2,361 - Q1 JCR: 9,3 - Q1 SCIE MIAR ICDS: 10,8 Artículo
Discovery of Highly Functionalized 5-hydroxy-2H-pyrrol-2-ones That Exhibit Antiestrogenic Effects in Breast and Endometrial Cancer Cells and Potentiate the Antitumoral Effect of Tamoxifen Guerra Rodríguez, Miguel; López-Rojas, Priscila; Amesty, Ángel; Aranda Tavío, Haidée Magdalena; Brito Casillas, Yeray Issued date: 2022 DOI: 10.3390/cancers14215174 Source: Cancers [2072-6694], v. 14(21): 5174 (Octubre 2022) SJR: 1,312 - Q1 JCR: 5,2 - Q2 MIAR ICDS: 10,6 Artículo
SOCS2 protects against chemical-induced hepatocellular carcinoma progression by modulating inflammation and cell proliferation in the liver Cabrera Galván, Juan José; Araujo Ruano, Eduardo; De Mirecki Garrido, Mercedes; Pérez Rodríguez, David; Guerra Hernández, Carlos Borja Issued date: 2022 DOI: 10.1016/j.biopha.2022.114060 Source: Biomedicine & Pharmacotherapy [ISSN 0753-3322], v. 157, 114060, (Enero 2023) SJR: 1,366 - Q1 JCR: 7,5 - Q1 SCIE MIAR ICDS: 11,0 Artículo
Galectin-9: A novel promoter of atherosclerosis progression Krautter, Franziska; Hussain, Mohammed T.; Zhi, Zhaogong; Lezama, Danielle R.; Manning, Julia E., et al Issued date: 2022 DOI: 10.1016/j.atherosclerosis.2022.11.014 Source: Atherosclerosis [ISSN 0021-9150], v. 363, p. 57-68, (Diciembre 2022) SJR: 1,375 - Q1 JCR: 5,3 - Q2 SCIE MIAR ICDS: 11,0 Artículo
JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia Aranda Tavío, Haidée Magdalena; Recio Cruz, Carlota Pilar; Martín-Acosta, Pedro; Guerra Rodríguez, Miguel Alfonso; Brito Casillas, Yeray Issued date: 2021 DOI: 10.1016/j.biopha.2021.112330 Source: Biomedicine and Pharmacotherapy [ISSN 0753-3322], v. 144, 112330, (Diciembre 2021) SJR: 1,194 - Q1 JCR: 7,419 - Q1 SCIE MIAR ICDS: 11,0 Artículo
The Mevalonate Pathway, a Metabolic Target in Cancer Therapy Guerra Hernández, Carlos Borja; Recio Cruz, Carlota Pilar; Aranda Tavío, Haidee Magdalena; Guerra Rodríguez, Miguel Alfonso; García Castellano, José Manuel Issued date: 2021 DOI: 10.3389/fonc.2021.626971 Source: Frontiers in Oncology [EISSN 2234-943X], v. 11, (Febrero 2021) SJR: 1,291 - Q1 JCR: 5,738 - Q2 SCIE MIAR ICDS: 10,5 Artículo
Characterisation of endogenous Galectin-1 and -9 expression in monocyte and macrophage subsets under resting and inflammatory conditions Krautter, Franziska; Recio Cruz, Carlota Pilar; Hussain, Mohammed T.; Lezama, Danielle R.; Maione, Francesco, et al Issued date: 2020 DOI: 10.1016/j.biopha.2020.110595 Source: Biomedicine and Pharmacotherapy [ISSN 0753-3322], v. 130, 110595 SJR: 1,323 - Q1 JCR: 6,529 - Q1 SCIE Artículo
JAK, an Oncokinase in Hematological Cancer Recio Cruz, Carlota Pilar; Aranda Tavío, Haidee Magdalena; Guerra Rodríguez, Miguel Alfonso; De Mirecki Garrido, Mercedes; Martín Rodríguez, Patricia Issued date: 2019 DOI: 10.5772/intechopen.84177 Source: Tyrosine Kinases as Druggable Targets in Cancer / Editado por Huan Ren Capítulo de libro
A Biased Agonist at Immunometabolic Receptor GPR84 Causes Distinct Functional Effects in Macrophages Lucy, Daniel; Purvis, Gareth S. D.; Zeboudj, Lynda; Chatzopoulou, Maria; Recio Cruz, Carlota Pilar Issued date: 2019 DOI: 10.1021/acschembio.9b00533 Source: ACS Chemical Biology [ISSN 1554-8929], v. 14 (9), p. 2055-2064 SJR: 2,013 - Q1 JCR: 4,434 - Q2 SCIE Artículo
Signal transducer and activator of transcription (STAT)-5: an opportunity for drug development in oncohematology Recio Cruz, Carlota Pilar; Guerra, Borja; Guerra Rodríguez, Miguel Alfonso; Aranda Tavío, Haidee Magdalena; Martín-Rodríguez, Patricia Issued date: 2019 DOI: 10.1038/s41388-019-0752-3 Source: Oncogene [ISSN 0950-9232], v. 38 (24), p. 4657-4668 SJR: 3,232 - Q1 JCR: 7,971 - Q1 SCIE Artículo
In Vitro Migration Assays Taylor, Lewis; Recio Cruz, Carlota Pilar; Greaves, David R.; Iqbal, Asif J. Issued date: 2018 DOI: 10.1007/978-1-4939-7837-3_19 Source: Macrophages: Methods and Protocols / Germain Rousselet (ed.), v. 1784, p. 197-214 Capítulo de libro
Nrf2 Activation Provides Atheroprotection in Diabetic Mice Through Concerted Upregulation of Antioxidant, Anti-inflammatory, and Autophagy Mechanisms Lazaro, Iolanda; Lopez-Sanz, Laura; Bernal, Susana; Oguiza, Ainhoa; Recio Cruz, Carlota Pilar Issued date: 2018 DOI: 10.3389/fphar.2018.00819 Source: Frontiers in Pharmacology [ISSN 1663-9812], v. 9, 819 SJR: 1,256 - Q1 JCR: 3,845 - Q1 SCIE Artículo
The Role of Metabolite-Sensing G Protein-Coupled Receptors in Inflammation and Metabolic Disease Recio Cruz, Carlota Pilar; Lucy, Daniel; Iveson, Poppy; Iqbal, Asif J.; Valaris, Sophia, et al Issued date: 2018 DOI: 10.1089/ars.2017.7168 Source: Antioxidants and Redox Signaling [ISSN 1523-0864], v. 29 (3), p. 237-256 SJR: 2,151 - Q1 JCR: 5,828 - Q1 SCIE Artículo
SOCS1-targeted therapy ameliorates renal and vascular oxidative stress in diabetes via STAT1 and PI3K inhibition López-Sanz, Laura; Bernal, Susana; Recio Cruz, Carlota Pilar; Lazaro, Iolanda; Oguiza, Ainhoa, et al Issued date: 2018 DOI: 10.1038/s41374-018-0043-6 Source: Laboratory Investigation [ISSN 0023-6837], n. 98, p. 1276-1290 SJR: 1,53 - Q1 JCR: 3,684 - Q1 SCIE Artículo
Activation of the Immune-Metabolic Receptor GPR84 Enhances Inflammation and Phagocytosis in Macrophages Recio Cruz, Carlota Pilar; Lucy, Daniel; Purvis, Gareth S. D.; Iveson, Poppy; Zeboudj, Lynda, et al Issued date: 2018 DOI: 10.3389/fimmu.2018.01419 Source: Frontiers in Immunology [ISSN 1664-3224], v. 9, 01419 SJR: 2,021 - Q1 JCR: 4,716 - Q2 SCIE Artículo